- Home
- JZ vs INM Comparison
JZ vs INM Comparison
Compare JZ & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- INM
- Stock Information
- Founded
- JZ 2011
- INM 1981
- Country
- JZ China
- INM Canada
- Employees
- JZ N/A
- INM N/A
- Industry
- JZ Other Consumer Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- JZ Real Estate
- INM Health Care
- Exchange
- JZ Nasdaq
- INM Nasdaq
- Market Cap
- JZ 4.9M
- INM 4.3M
- IPO Year
- JZ 2022
- INM N/A
- Fundamental
- Price
- JZ $1.64
- INM $2.28
- Analyst Decision
- JZ
- INM
- Analyst Count
- JZ 0
- INM 0
- Target Price
- JZ N/A
- INM N/A
- AVG Volume (30 Days)
- JZ 22.6K
- INM 93.9K
- Earning Date
- JZ 09-26-2025
- INM 11-13-2025
- Dividend Yield
- JZ N/A
- INM N/A
- EPS Growth
- JZ N/A
- INM N/A
- EPS
- JZ N/A
- INM N/A
- Revenue
- JZ $34,090,704.00
- INM $4,942,633.00
- Revenue This Year
- JZ N/A
- INM N/A
- Revenue Next Year
- JZ N/A
- INM N/A
- P/E Ratio
- JZ N/A
- INM N/A
- Revenue Growth
- JZ N/A
- INM 7.50
- 52 Week Low
- JZ $1.30
- INM $1.72
- 52 Week High
- JZ $14.60
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- JZ 47.59
- INM 49.66
- Support Level
- JZ $1.62
- INM $2.17
- Resistance Level
- JZ $1.83
- INM $2.30
- Average True Range (ATR)
- JZ 0.11
- INM 0.12
- MACD
- JZ -0.02
- INM 0.01
- Stochastic Oscillator
- JZ 8.24
- INM 41.16
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.